SC 13D/A:超过5%持股股东披露文件(修正)-Deerfield Management Company, L.P.(8.75%),James E. Flynn(8.75%)等
4:持股变动声明-股东 OrbiMed Israel BioFund GP Limited Partnership
4:持股变动声明-股东 Cystic Fibrosis Foundation
BiomX | 3:首次持股声明-董事 Blum Susan
BiomX | D:发行公告
BiomX | 3:首次持股声明-股东 Cystic Fibrosis Foundation
BiomX | SC 13G/A:超过5%持股股东披露文件(修正)-Cystic Fibrosis Foundation(15.6%)
BiomX | SC 13G:超过5%持股股东披露文件-AMR Action Fund, L.P.(5.5%),AMR Action Fund GP, LLC(5.5%)等
BiomX | SC 13D:超过5%持股股东披露文件-Deerfield Management Company, L.P.(11.06%),James E. Flynn(11.06%)等
BiomX | 3:首次持股声明-董事 Merril Gregory Louis
BiomX | 3:首次持股声明-董事 LEFF JONATHAN S
BiomX | 3:首次持股声明-董事 GOODMAN JESSE
BiomX | 4:持股变动声明-董事 Flynn James E
BiomX | 3:首次持股声明-董事 Flynn James E
BiomX | SC 13D/A:超过5%持股股东披露文件(修正)-OrbiMed Israel GP Ltd.(19.9%),OrbiMed Israel BioFund GP Limited Partnership(19.9%)等
BiomX | 4:持股变动声明-股东 OrbiMed Israel BioFund GP Limited Partnership
BiomX | SC 13D/A:超过5%持股股东披露文件(修正)-OrbiMed Israel GP Ltd.(9.9%),OrbiMed Israel BioFund GP Limited Partnership(9.9%)等
BiomX | SC 13G/A:超过5%持股股东披露文件(修正)-MMCAP International Inc. SPC(3.22%),MM Asset Management Inc.(3.22%)
BiomX | SC 13G/A:超过5%持股股东披露文件(修正)-Johnson & Johnson(4.6%),Johnson & Johnson Innovation-JJDC, Inc.(4.6%)
BiomX | SC 13G/A:超过5%持股股东披露文件(修正)-Cystic Fibrosis Foundation(9.90%)
暂无数据